Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: Transmission through four generations

Katherine A Rauen, William E. Tidyman, Anne L. Estep, Srirangan Sampath, Henry M. Peltier, Sherri J. Bale, Yves Lacassie

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Cardio-facio-cutaneous (CFC) syndrome is one of the RASopathies and is caused by alteration of activity through the Ras/ mitogen-activated protein kinase (MAPK) pathway due to heterozygous de novo mutations in protein kinases BRAF, MEK1, or MEK2. CFC is a rare multiple congenital anomaly disorder in which individuals have characteristic dysmorphic features, cardiac defects, ectodermal anomalies and developmental delay.We report a 71/2-month-old boy with a clinical diagnosis of CFC. Bidirectional sequence analysis of MEK2 revealed a novel c.383C→Atransversion in exon 3 resulting in a nonsynonymous missense substitution, p.P128Q. Other family members, including the proband's mother and half-sibling, displayed phenotypic features of CFC and were also screened for the MEK2 mutation identified in the proband. Sorting Intolerant From Tolerant (SIFT) analysis determined the novel MEK2 p.P128Q to be deleterious. To corroborate the functional alteration of the novel mutant protein, transient transfection of HEK 293T cells with subsequent Western analysis was used to demonstrate increased kinase activity, as measured by ERK phosphorylation. This first reported case of a vertically transmitted functional CFC MEK mutation further expands our understanding of germline mutations within the Ras/MAPK pathway.

Original languageEnglish (US)
Pages (from-to)807-814
Number of pages8
JournalAmerican Journal of Medical Genetics, Part A
Volume152
Issue number4
DOIs
StatePublished - Apr 2010
Externally publishedYes

Fingerprint

Skin
Mutation
Mitogen-Activated Protein Kinases
MAP Kinase Kinase 1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Germ-Line Mutation
HEK293 Cells
Mitogen-Activated Protein Kinase Kinases
Mutant Proteins
Transfection
Sequence Analysis
Siblings
Exons
Phosphotransferases
Phosphorylation
Mothers
Cardiofaciocutaneous syndrome

Keywords

  • Acute lymphoblastic leukemia
  • Autosomal dominant
  • BRAF
  • Cardio-facio-cutaneous syndrome
  • MEK1
  • MEK2
  • Multiple generation transmission
  • Ras/MAPK
  • RASopathy
  • Signal transduction pathway

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome : Transmission through four generations. / Rauen, Katherine A; Tidyman, William E.; Estep, Anne L.; Sampath, Srirangan; Peltier, Henry M.; Bale, Sherri J.; Lacassie, Yves.

In: American Journal of Medical Genetics, Part A, Vol. 152, No. 4, 04.2010, p. 807-814.

Research output: Contribution to journalArticle

Rauen, Katherine A ; Tidyman, William E. ; Estep, Anne L. ; Sampath, Srirangan ; Peltier, Henry M. ; Bale, Sherri J. ; Lacassie, Yves. / Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome : Transmission through four generations. In: American Journal of Medical Genetics, Part A. 2010 ; Vol. 152, No. 4. pp. 807-814.
@article{f7405b12c2f043c2bcc50fcffe5ff211,
title = "Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: Transmission through four generations",
abstract = "Cardio-facio-cutaneous (CFC) syndrome is one of the RASopathies and is caused by alteration of activity through the Ras/ mitogen-activated protein kinase (MAPK) pathway due to heterozygous de novo mutations in protein kinases BRAF, MEK1, or MEK2. CFC is a rare multiple congenital anomaly disorder in which individuals have characteristic dysmorphic features, cardiac defects, ectodermal anomalies and developmental delay.We report a 71/2-month-old boy with a clinical diagnosis of CFC. Bidirectional sequence analysis of MEK2 revealed a novel c.383C→Atransversion in exon 3 resulting in a nonsynonymous missense substitution, p.P128Q. Other family members, including the proband's mother and half-sibling, displayed phenotypic features of CFC and were also screened for the MEK2 mutation identified in the proband. Sorting Intolerant From Tolerant (SIFT) analysis determined the novel MEK2 p.P128Q to be deleterious. To corroborate the functional alteration of the novel mutant protein, transient transfection of HEK 293T cells with subsequent Western analysis was used to demonstrate increased kinase activity, as measured by ERK phosphorylation. This first reported case of a vertically transmitted functional CFC MEK mutation further expands our understanding of germline mutations within the Ras/MAPK pathway.",
keywords = "Acute lymphoblastic leukemia, Autosomal dominant, BRAF, Cardio-facio-cutaneous syndrome, MEK1, MEK2, Multiple generation transmission, Ras/MAPK, RASopathy, Signal transduction pathway",
author = "Rauen, {Katherine A} and Tidyman, {William E.} and Estep, {Anne L.} and Srirangan Sampath and Peltier, {Henry M.} and Bale, {Sherri J.} and Yves Lacassie",
year = "2010",
month = "4",
doi = "10.1002/ajmg.a.33342",
language = "English (US)",
volume = "152",
pages = "807--814",
journal = "American Journal of Medical Genetics",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome

T2 - Transmission through four generations

AU - Rauen, Katherine A

AU - Tidyman, William E.

AU - Estep, Anne L.

AU - Sampath, Srirangan

AU - Peltier, Henry M.

AU - Bale, Sherri J.

AU - Lacassie, Yves

PY - 2010/4

Y1 - 2010/4

N2 - Cardio-facio-cutaneous (CFC) syndrome is one of the RASopathies and is caused by alteration of activity through the Ras/ mitogen-activated protein kinase (MAPK) pathway due to heterozygous de novo mutations in protein kinases BRAF, MEK1, or MEK2. CFC is a rare multiple congenital anomaly disorder in which individuals have characteristic dysmorphic features, cardiac defects, ectodermal anomalies and developmental delay.We report a 71/2-month-old boy with a clinical diagnosis of CFC. Bidirectional sequence analysis of MEK2 revealed a novel c.383C→Atransversion in exon 3 resulting in a nonsynonymous missense substitution, p.P128Q. Other family members, including the proband's mother and half-sibling, displayed phenotypic features of CFC and were also screened for the MEK2 mutation identified in the proband. Sorting Intolerant From Tolerant (SIFT) analysis determined the novel MEK2 p.P128Q to be deleterious. To corroborate the functional alteration of the novel mutant protein, transient transfection of HEK 293T cells with subsequent Western analysis was used to demonstrate increased kinase activity, as measured by ERK phosphorylation. This first reported case of a vertically transmitted functional CFC MEK mutation further expands our understanding of germline mutations within the Ras/MAPK pathway.

AB - Cardio-facio-cutaneous (CFC) syndrome is one of the RASopathies and is caused by alteration of activity through the Ras/ mitogen-activated protein kinase (MAPK) pathway due to heterozygous de novo mutations in protein kinases BRAF, MEK1, or MEK2. CFC is a rare multiple congenital anomaly disorder in which individuals have characteristic dysmorphic features, cardiac defects, ectodermal anomalies and developmental delay.We report a 71/2-month-old boy with a clinical diagnosis of CFC. Bidirectional sequence analysis of MEK2 revealed a novel c.383C→Atransversion in exon 3 resulting in a nonsynonymous missense substitution, p.P128Q. Other family members, including the proband's mother and half-sibling, displayed phenotypic features of CFC and were also screened for the MEK2 mutation identified in the proband. Sorting Intolerant From Tolerant (SIFT) analysis determined the novel MEK2 p.P128Q to be deleterious. To corroborate the functional alteration of the novel mutant protein, transient transfection of HEK 293T cells with subsequent Western analysis was used to demonstrate increased kinase activity, as measured by ERK phosphorylation. This first reported case of a vertically transmitted functional CFC MEK mutation further expands our understanding of germline mutations within the Ras/MAPK pathway.

KW - Acute lymphoblastic leukemia

KW - Autosomal dominant

KW - BRAF

KW - Cardio-facio-cutaneous syndrome

KW - MEK1

KW - MEK2

KW - Multiple generation transmission

KW - Ras/MAPK

KW - RASopathy

KW - Signal transduction pathway

UR - http://www.scopus.com/inward/record.url?scp=77950409870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950409870&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.33342

DO - 10.1002/ajmg.a.33342

M3 - Article

C2 - 20358587

AN - SCOPUS:77950409870

VL - 152

SP - 807

EP - 814

JO - American Journal of Medical Genetics

JF - American Journal of Medical Genetics

SN - 1552-4825

IS - 4

ER -